D Y Kim Selected Research

D Y Kim Research Topics

Disease

14	Neoplasms (Cancer) 01/2021 - 06/2000
7	Infections 12/2015 - 09/2000
7	Carcinoma (Carcinomatosis) 01/2015 - 06/2000
4	Stomach Neoplasms (Stomach Cancer) 09/2003 - 11/2000
4	Carcinogenesis 12/2001 - 11/2000
3	Necrosis 02/2016 - 12/2009
3	Hemorrhage 03/2012 - 03/2001
3	Wounds and Injuries (Trauma) 09/2002 - 01/2001
2	Urinary Tract Infections (Urinary Tract Infection) 10/2023 - 08/2023
2	Sepsis (Septicemia) 08/2023 - 04/2012
2	Chronic Hepatitis B 01/2017 - 08/2008
2	Stroke (Strokes) 11/2016 - 09/2007
2	Breast Neoplasms (Breast Cancer) 01/2016 - 03/2000
2	Overactive Urinary Bladder (Overactive Bladder) 02/2014 - 02/2000
2	Lymphoma (Lymphomas) 02/2014 - 10/2001
2	Colorectal Neoplasms (Colorectal Cancer) 09/2013 - 07/2000
2	Rectal Neoplasms (Rectal Cancer) 06/2012 - 03/2006
2	Neoplasm Metastasis (Metastasis) 06/2012 - 06/2012
2	Fibrosis (Cirrhosis) 11/2010 - 11/2009
2	Hyperplasia 01/2009 - 06/2000
2	Adenocarcinoma 01/2009 - 12/2000
2	Liver Diseases (Liver Disease) 08/2008 - 03/2007
1	Bacteriuria 10/2023
1	Communicable Diseases (Infectious Diseases) 10/2023
1	COVID-19 08/2023
1	Ventilator-Associated Pneumonia 08/2023
1	Ischemic Stroke 01/2022
1	Autoimmune Diseases (Autoimmune Disease) 10/2021
1	Overweight 01/2021
1	Surgical Wound Infection 01/2021
1	Sarcoma (Soft Tissue Sarcoma) 11/2020
1	Hypoxia (Hypoxemia) 01/2019
1	Alopecia (Baldness) 01/2019
1	Ischemia 01/2019
1	B-Cell Lymphoma (Lymphoma, B Cell) 12/2017
1	B-Cell Leukemia (Leukemia, B Cell) 12/2017
1	T-Cell Leukemia (Leukemia, T Cell) 12/2017
1	Mucocutaneous Lymph Node Syndrome (Kawasaki Disease) 05/2017
1	Hemorrhagic Stroke 11/2016
1	Hyperglycemia 11/2016
1	Behcet Syndrome (Behcet's Syndrome) 06/2016
1	Catheter-Related Infections 03/2016
1	Anaphylaxis (Anaphylactic Shock) 02/2016
1	Ductal Carcinoma 01/2016

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 12/2017 - 06/2000
4	Messenger RNA (mRNA)IBA 12/2017 - 12/2000
3	Biomarkers (Surrogate Marker)IBA 05/2017 - 11/2014
3	LipidsIBA 02/2014 - 06/2000
2	Anti-Bacterial Agents (Antibiotics)IBA 10/2023 - 01/2021
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2019 - 09/2013
2	Immunoglobulin E (IgE)IBA 02/2016 - 12/2009
2	ilaprazoleIBA 09/2014 - 09/2000
2	AntibodiesIBA 12/2013 - 10/2002
2	Interleukin-4 (Interleukin 4)IBA 12/2013 - 12/2009
2	Carcinoembryonic AntigenIBA 09/2013 - 07/2000
2	PlatinumIBA 01/2006 - 03/2003
2	Cyclin D1IBA 12/2000 - 06/2000
2	CyclinsIBA 12/2000 - 06/2000
1	Aquaporin 5IBA 10/2021
1	Carbon DioxideIBA 11/2020
1	Acetylcysteine (Siran)FDA LinkGeneric 01/2019
1	Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA 01/2019
1	Conditioned Culture MediaIBA 01/2019
1	NADPH Oxidase 4IBA 01/2019
1	SolutionsIBA 01/2019
1	Green Fluorescent ProteinsIBA 01/2019
1	Mitogen-Activated Protein KinasesIBA 01/2019
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2019
1	NADPH Oxidases (NAD(P)H oxidase)IBA 01/2019
1	diphenyleneiodoniumIBA 01/2019
1	Alkaline PhosphataseIBA 01/2019
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2019
1	SodiumIBA 01/2019
1	B7-H1 AntigenIBA 12/2017
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 12/2017
1	entecavir FDA Link 01/2017
1	Tenofovir (Viread)FDA Link 01/2017
1	Lamivudine (Epivir)FDA Link 01/2017
1	IgE Receptors (Fc epsilon RI)IBA 02/2016
1	NecroX-5IBA 02/2016
1	Anti-Allergic Agents (Antiallergic Agents)IBA 02/2016
1	Myosin Type IIIBA 01/2016
1	Small Interfering RNA (siRNA)IBA 01/2016

Therapy/Procedure

8	Therapeutics 01/2017 - 03/2001
8	Drug Therapy (Chemotherapy) 09/2013 - 02/2001
6	Liver Transplantation 04/2014 - 12/2006
4	Chemoradiotherapy 06/2012 - 01/2001
4	Radiotherapy 03/2006 - 03/2000
2	Catheters 08/2023 - 03/2016
2	Transplantation 04/2012 - 06/2000
2	Cytoreduction Surgical Procedures 01/2006 - 01/2006
2	Combination Drug Therapy (Combination Chemotherapy) 01/2006 - 01/2006
2	Surgical Amputation (Amputations) 01/2001 - 08/2000
1	Thrombectomy 01/2022
1	Herniorrhaphy 01/2021
1	Length of Stay 01/2021
1	Gas Lasers 11/2020
1	Lasers (Laser) 11/2020
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2019
1	Oral Administration 02/2016